TENARIS SA (TS)
Tenaris anuncia la sucesión de su CEO
Tenaris anuncia la sucesión de su CEO
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
Volaris Reports April 2026 Traffic Results: Load Factor of 85%
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
Gates Industrial to Participate in the 19th Annual Wolfe Research Global Transportation & Industrials Conference
Inspired Entertainment Extends Long-Term Agreement with Paddy Power for Gaming Terminals and Content
Magnera Reports Second Quarter Results
Autoliv Declares Quarterly Dividend USA - English USA - English
Autoliv Declares Quarterly Dividend